Last $30.00 USD
Change Today -0.42 / -1.38%
Volume 814.2K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven M. Rauscher M.B.A.

Director and Chairman of Compliance Committee, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
60$228,544

Background*

Mr. Steven M. Rauscher, also known as Steve, MBA, served as the President and Chief Executive Officer of Oscient Pharmaceuticals Corporation since October 2000. Mr. Rauscher served as the President and Principal Executive Officer of Guardian II Acquisition Corporation. He served as the Chief Executive Officer of AmericasDoctor, Inc. Affiliated Research Centers, Inc. since 1995. He served as the General Manager of Abbott West Indies. Mr. Rauscher was employed by Abbott ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Director
Former Principal Executive Officer, President, Director, Principal Executive Officer of Oscient Pharmaceuticals Corporation, President of Oscient Pharmaceuticals Corporation and Director of Oscient Pharmaceuticals Corporation
1993-N/A
Former Chief Executive Officer, President, Director, Chief Executive Officer of Guardian Ii Acquisition Corporation and President of Guardian Ii Acquisition Corporation
2005-Present
Director and Chairman of Compliance Committee

Education*

MBA
The University of Chicago
BS
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$59,000
Total Calculated Compensation$228,544
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $30.00 USD -0.42

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.